Medicare Enrolled

Dr. Elizabeth Tito, MD

Surgery · Santa Rosa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
121 SOTOYOME ST STE 203, Santa Rosa, CA 95405
7075256180
In practice since 2006 (19 years)
NPI: 1629092309 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tito from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tito? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tito

Dr. Elizabeth Tito is a surgery specialist in Santa Rosa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tito performed 585 Medicare services across 521 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tito received a total of $3,729 from 38 pharmaceutical and/or device companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tito is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $3,729 industry payments

Medicare Practice Summary

Medicare Utilization ↗
585
Medicare services
Top 17% in CA for surgery
521
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
150 $68 $245
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
138 $20 $65
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
71 $8 $13
Partial removal of breast 46 $478 $1,752
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $121 $447
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $101 $345
New patient office visit, complex (60-74 min) 31 $186 $591
Deep underarm lymph node biopsy or removal
A procedure to remove or sample deep lymph nodes located in the underarm area for examination.
28 $197 $1,186
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
23 $87 $302
Intraoperative lymph node imaging
Imaging performed during surgery to visualize lymph nodes.
22 $112 $363
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,729
Total received (2018-2024)
Avg $533/year across 7 years
Top 40% in CA for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
162
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,729 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$567
2023
$634
2022
$477
2021
$541
2020
$707
2019
$439
2018
$364

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$141
Regeneron Healthcare Solutions, Inc.
$110
Daiichi Sankyo Inc.
$63
AstraZeneca Pharmaceuticals LP
$56
Janssen Biotech, Inc.
$52
GlaxoSmithKline, LLC.
$45
SpringWorks Therapeutics, Inc.
$37
SERVIER PHARMACEUTICALS LLC
$34
Celgene Corporation
$30
Top 3 companies account for 55.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$694
AstraZeneca Pharmaceuticals LP
$375
Regeneron Healthcare Solutions, Inc.
$219
Seagen Inc.
$194
Celgene Corporation
$165
Janssen Biotech, Inc.
$142
PFIZER INC.
$141
GlaxoSmithKline, LLC.
$136
Novartis Pharmaceuticals Corporation
$131
Exelixis Inc.
$118
Daiichi Sankyo Inc.
$117
Lilly USA, LLC
$113
Merck Sharp & Dohme Corporation
$112
Incyte Corporation
$104
Eisai Inc.
$89
Foundation Medicine, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$79
BeiGene USA, Inc.
$76
EISAI INC.
$61
SERVIER PHARMACEUTICALS LLC
$59
Alexion Pharmaceuticals, Inc.
$47
Rigel Pharmaceuticals, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$45
Taiho Oncology, Inc.
$40
Genentech USA, Inc.
$39
SpringWorks Therapeutics, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$36
Medtronic USA, Inc.
$31
GE HealthCare
$26
Agios Pharmaceuticals, Inc.
$23
MorphoSys, US Inc.
$21
TAIHO ONCOLOGY, INC.
$20
EMD Serono, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$18
Pacira Pharmaceuticals Incorporated
$18
JAZZ PHARMACEUTICALS INC.
$18
Jazz Pharmaceuticals Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$15
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Aranesp · BRUKINSA · Bavencio · CABOMETYX · Cabometyx · ELREXFIO · ENHERTU · ERLEADA · EVENITY · EXPAREL · Enhertu · FOUNDATIONONE · Halaven · IBRANCE · IMBRUVICA · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · NINLARO · Neulasta · Nplate · OGSIVEO · OJJAARA · OPDUALAG · Otezla · PADCEV · PEMAZYRE · Perjeta · PlasmaBlade · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Stivarga · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · ULTOMIRIS · Ultomiris · VERZENIO · Vitrakvi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a surgery specialist in Santa Rosa?
Compare surgerists in the Santa Rosa area by procedure volume, costs, and industry payment transparency.
Browse surgerists nearby

Geographic Context

Surgerists within 10 mi
43
Per 100K population
8.9
County median income
$102,840
Nearest hospital
PROVIDENCE SANTA ROSA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tito is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tito experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Tito performed 150 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tito receive payments from pharmaceutical companies?
Yes. Dr. Tito received a total of $3,729 from 38 companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tito's costs compare to other surgerists in Santa Rosa?
Dr. Tito's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tito) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →